Hbk Investments L P Merck & Co., Inc. Transaction History

Hbk Investments L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $3.01 Million - $3.28 Million	27,712 New	27,712 $3.2 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.26 Million - $1.39 Million	-17,624 Reduced 58.14%	12,689 $953,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1.02 Million - $1.12 Million	14,458 Added 91.19%	30,313 $2.36 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $734,598 - $865,281	10,668 Added 205.67%	15,855 $1.22 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $1.4 Million - $1.58 Million	-18,013 Reduced 77.64%	5,187 $472,000
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $2.91 Million - $3.17 Million	-38,267 Reduced 62.26%	23,200 $1.95 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $12.8 Million - $14.6 Million	-184,035 Reduced 74.96%	61,467 $5.11 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $17.1 Million - $20.4 Million	-331,098 Reduced 57.42%	245,502 $13.8 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $33.8 Million - $36.4 Million	576,600	576,600 $36.9 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.